Kevin Brennan

Insider Reports History

Location
Waltham, MA
Signature
/s/ Kevin Brennan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Brennan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. SVP, FINANCE AND ACCOUNTING Restricted Stock Units 15K $15.6K $1.04 01 Jan 2025 Direct
Xilio Therapeutics, Inc. SVP, FINANCE AND ACCOUNTING Common stock 3.2K $3.15K $0.98 02 Jan 2025 Direct
Xilio Therapeutics, Inc. SVP, FINANCE AND ACCOUNTING Stock Option (right to buy) 20K 21 Nov 2025 Direct

Insider Reports Filed by Kevin Brennan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XLO Xilio Therapeutics, Inc. 21 Nov 2025 7 $0 4 25 Nov 2025 SVP, FINANCE AND ACCOUNTING
XLO Xilio Therapeutics, Inc. 01 Jan 2025 4 -$1.77K 4 03 Jan 2025 SVP, FINANCE AND ACCOUNTING
XLO Xilio Therapeutics, Inc. 01 Oct 2024 1 $0 4 02 Oct 2024 SVP, FINANCE AND ACCOUNTING
XLO Xilio Therapeutics, Inc. 01 May 2024 1 $0 4 03 May 2024 SVP, FINANCE AND ACCOUNTING
XLO Xilio Therapeutics, Inc. 01 Jan 2024 1 $0 4 03 Jan 2024 SVP, FINANCE AND ACCOUNTING
XLO Xilio Therapeutics, Inc. 16 Aug 2023 1 $0 4 18 Aug 2023 SVP, FINANCE AND ACCOUNTING
XLO Xilio Therapeutics, Inc. 01 Apr 2023 1 $0 4 03 Apr 2023 SVP, FINANCE AND ACCOUNTING
XLO Xilio Therapeutics, Inc. 30 Mar 2023 0 $0 3 03 Apr 2023 SVP, FINANCE AND ACCOUNTING